News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Kenneth M. Verburg, for the SUCCESS VI Study Group (Reprinted from Th

Articles by Kenneth M. Verburg, for the SUCCESS VI Study Group (Reprinted from Th

Cyclooxygenase-2-Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients

ByAndrew Whelton,John G. Fort,Joseph A. Puma,Diane Normandin,Alfonso E. Bello,Kenneth M. Verburg, for the SUCCESS VI Study Group (Reprinted from Th

October 1st 2002

Latest Updated Articles

Cyclooxygenase-2-Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients
October 1st 2002

Trending on AJMC

Delayed Dupilumab Raises Asthma Costs 32%: Nicola Hanania, MD

Across the US, Obesity Care Still Lacks an Owner

Aspirin's CRC Benefit Narrows to PIK3CA Exon 9/20 Mutations

A Patient-Centered Reconstruction of 340B in Oncology: Transparency, Equity, and Site-of-Care Accountability

FDA Expands Finerenone Approval to CKD Associated With Type 1 Diabetes